Symbol | Company | Weighting |
---|---|---|
LLY | ELI LILLY CORP | 10.69% |
VRTX | VERTEX PHARMACEUTICALS INC | 6.50% |
REGN | REGENERON PHARMACEUTICALS | 5.56% |
UNH | UNITEDHEALTH GROUP INC | 5.01% |
ZTS | ZOETIS INC | 4.97% |
MDT | MEDTRONIC PLC | 4.35% |
CI | THE CIGNA GROUP | 4.24% |
TMO | THERMO FISHER SCIENTIFIC INC | 4.03% |
GILD | GILEAD SCIENCES INC | 3.84% |
DHR | DANAHER CORP | 3.81% |
EW | EDWARDS LIFESCIENCES CORP | 3.76% |
MRK | MERCK & CO. NEW | 3.75% |
BDX | BECTON DICKINSON & CO | 3.66% |
JNJ | JOHNSON & JOHNSON | 3.55% |
THC | TENET HEALTHCARE CORP | 3.25% |
CVS | CVS HEALTH CORPORATION | 2.93% |
BMY | BRISTOL MYERS SQUIBB CO | 2.82% |
PFE | PFIZER INC | 2.38% |
LNTH | LANTHEUS HOLDINGS INC | 2.33% |
HUM | HUMANA INC | 2.10% |
ITCI | INTRA-CELLULAR THERAPIES USD | 1.83% |
AVTR | AVANTOR, INC. | 1.65% |
IQV | IQVIA HOLDINGS INC | 1.53% |
VEEV | VEEVA SYSTEMS INC CLASS A | 1.38% |
CRL | CHARLES RIVER LABORATORIES INT INC | 1.15% |
JAZZ | JAZZ PHARMACEUTICALS PLC | 1.13% |
TNDM | TANDEM DIABETES CARE INC | 1.08% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.01% |
LH | LABCORP HOLDINGS INC | 0.91% |
GH | GUARDANT HEALTH INC | 0.77% |
PRVA | PRIVIA HEALTH GROUP INC | 0.76% |
DXCM | DEXCOM INC | 0.73% |
ACHC | ACADIA HEALTHCARE CO INC | 0.72% |
PINC | PREMIER INC | 0.64% |
NTLA | INTELLIA THERAPEUTICS INC | 0.57% |
VLTO | VERALTO CORP | 0.53% |
FTRE | FORTREA HOLDINGS INC | 0.08% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available), click here or contact us.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC ("GFIA") and Guggenheim Partners Investment Management ("GPIM"), the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.
© 2024 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
FOR MERRILL LYNCH ADVISOR USE ONLY
This material may not be reproduced or shown to the members of the general public or used in written form as sales literature; any such use would be contrary to the FINRA Conduct Rules.
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.